Skip to main content

Table 4 Laboratory trials using Bacillus thuringiensis var. israelensis and Bacillus sphaericus against malaria vectors in sub-Saharan Africa

From: Bacterial larvicides used for malaria vector control in sub-Saharan Africa: review of their effectiveness and operational feasibility

Site (Country)

Bacterial strain (potency)

Product (formulations)

Species tested

(larval instar)

Exposure time (h)

LC50

LC90/95

References

ICIPE (Kenya)

Bti (2700 ITU/mg)

VectoBac® (WDG)

An. gambiae (s.s.) (3rd)

24

0.021

0.201

[67]

Bs (650 BsITU/mg)

VectoLex® (WDG)

An. gambiae (s.s.) (3rd)

24

0.004

0.038

Bti (10000 ITU/mg)

Bactimos® (PP)

An. gambiae (s.s.) (3rd)

24

0.006

0.090

Bs (1600 ITU/mg)

(TP)

An. gambiae (s.s.) (3rd)

24

0.002

0.018

Ouagadougou (Burkina Faso)

Bti (3500 ITU/mg)

Bactimos® (WP)

An. gambiae (s.l.) (3rd and 4th)

24

0.081

0.231a

[70]

Bti (2000 ITU/mg)

VectoBac® (WP)

An. gambiae (s.l.) (3rd and 4th)

24

0.110

0.375a

Bti (1500 ITU/mg)

Teknar (FC)

An. gambiae (s.l.) (3rd and 4th)

24

0.662

1.743a

Bs (not stated)

1593 IF-119 (SD)

An. gambiae (s.l.) (3rd and 4th)

48

0.043

0.107a

Bs (not stated)

2362 IF-118 (SD)

An. gambiae (s.l.) (3rd and 4th)

48

0.022

0.130a

MRC, Farafenni (Gambia)

Bs (650 Bs ITU/mg)

VectoLex® (WDG)

An. gambiae (s.s.) (3rd)

24

0.004

0.023

[69]

Bti (3000 ITU/mg)

VectoBac® (WDG)

An. gambiae (s.s.) (3rd)

24

0.039

0.132

KEMRI, Kisumu (Kenya)

Bti (7000 ITU/mg)

Not stated

An. gambiae (s.l.) (3rd)

24

0.062

0.797

[21]

Bs (1000 ITU/mg)

Not stated

An. gambiae (s.l.) (3rd)

48

0.058

0.451

KCCR, Kumasi (Ghana)

Bti (3000 ITU/mg)

VectoBac® (WDG)

An. gambiae (3rd)

24

0.026

0.136

[68]

Bobo-Dioulasso (Burkina Faso)

Bs (not stated)

(FC)

An. gambiae (s.s.) (3rd)

48

0.342

1.807

[20]

UFS, Muheza (Tanzania)

Bs (not stated)

Spherimos (FC)

An. funestus (4th)

48

1.0

6.0

[26]

KCCR, Kumasi (Ghana)

Bs (not stated)

VectoLex® (WDG)

An. gambiae (s.l.) (3rd and 4th)

24

0.0027

0.0086

[66]

NOCMVD, Nazareth (Ethiopia)

Bti (not stated)

IPS-82

An. arabiensis (3rd)

48

0.0018b

–

[65]

Bs (not stated)

SPH-88

An. arabiensis (3rd)

48

0.0076b

–

NICD, Johannesburg (South Africa)

Bti (not stated)

Not stated

An. quadriannulatus (3rd)

24

2.97

5.02

[64]

–

An. arabiensis (3rd)

24

3.72

10.10a

–

An. gambiae (3rd)

24

3.76

7.70a

–

An. merus (3rd)

24

3.82

6.65a

–

An. funestus (3rd)

24

4.44

13.50a

  1. aLC90/95: a dose marked with a represents LC90; unmarked doses represent LC95
  2. bDoses provided in µg/l were converted to mg/l for a uniform presentation. Concentrations reported in mg/l except for study [64] are given in 104 spores/ml
  3. Abbreviations: Bti, Bacillus thuringiensis var. israelensis; Bs, Bacillus sphaericus; ITU, international toxic units; WDG, water-dispersible granules; PP, primary powder; TP, technical powder; FC, flowable concentrate; SD, spray dried; ICIPE, International Centre of Insect Physiology and Ecology; MRC, Medical Research Council; KCCR, Kumasi Centre for Collaborative Research; UFS, Ubwari Field Station; NOCMVD, National Organization for the Control of Malaria and other Vector-borne Diseases; NICD, National Institute of Communicable Diseases; LC, lethal concentration (concentration that kills 50/95% of the test subjects)